SKI Market

Indian Indices

Nifty

26,186.45 152.70
(0.59%)

Sensex

85,712.37 447.05
( 0.52%)

Bank Nifty

59,777.20 488.50
( 0.82%)

Nifty IT

38,703.65 343.40
( 0.90%)

Global Indices

Nasdaq

47,981.01 109.07
(0.23%)

Dow Jones

6,892.33 14.21
(0.21%)

Hang Seng

50,440.45 -587.97
(-1.15%)

Nikkei 225

9,667.01 -43.86
(-0.45%)

Forex

USD-INR

89.99 -0.14
(-0.16%)

EUR-INR

104.92 -0.11
(-0.11%)

GBP-INR

120.05 0.29
(0.24%)

JPY-INR

0.58 0.00
(0.11%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Hester Biosciences Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524669

INE782E01017

409.0776861

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

HESTERBIO

48.17

1402.78

EPS(TTM)

Face Value()

Div & Yield %

34.23

0.42

Back

hardwyn india ltd

Kirloskar Brothers consolidated net profit declines 25.81% in the September 2025 quarter

Nov 03,2025

Net profit of Kirloskar Brothers declined 25.81% to Rs 71.00 crore in the quarter ended September 2025 as against Rs 95.70 crore during the previous quarter ended September 2024. Sales declined 0.78% to Rs 1027.70 crore in the quarter ended September 2025 as against Rs 1035.80 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1027.70	1035.80	-1
OPM %	10.55	13.72	-
PBDT	117.00	150.80	-22
PBT	93.10	128.80	-28
NP	71.00	95.70	-26

26,186.45 152.70 (0.59%)

85,712.37 447.05 ( 0.52%)

59,777.20 488.50 ( 0.82%)

38,703.65 343.40 ( 0.90%)

47,981.01 109.07 (0.23%)

6,892.33 14.21 (0.21%)

50,440.45 -587.97 (-1.15%)

9,667.01 -43.86 (-0.45%)

89.99 -0.14 (-0.16%)

104.92 -0.11 (-0.11%)

120.05 0.29 (0.24%)

0.58 0.00 (0.11%)